20231127 lab meeting_庭汶 | 賴亮全實驗室

索引

00:00 1.
index 1
14:20 2.
A microRNA-21–mediated SATB1/S100A9/NF-kBaxis promotes chronic obstructive pulmonarydisease pathogenesis
14:47 3.
Slide 2
15:54 4.
Classification of severity in COPD
16:32 5.
The pulmonary function parameter
16:32 6.
The Lung Function Test
16:33 7.
The pulmonary function parameter
16:33 8.
Classification of severity in COPD
16:38 9.
The pulmonary function parameter
22:17 10.
The Lung Function Test
23:00 11.
White blood cells participates in airway inflammation
23:56 12.
So, why the author chose miR-21 as a target gene?
24:23 13.
CS induces lung miR-21 expression in COPD
26:34 14.
miR-21 positive signals in the airway epithium
26:36 15.
CS induces lung miR-21 expression in COPD
31:56 16.
miR-21 positive signals in the airway epithium
43:43 17.
Correlation between miR-21 expression and disease severity in COPD.
53:44 18.
miR-21 expression in different phase of COPD
54:15 19.
Summary
54:43 20.
Inhibition of miR-21 suppresses airway inflammation.
1:02:59 21.
The effectiveness of Ant-21 treatment in COPD
1:04:44 22.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:06:31 23.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:09:50 24.
Summary
1:10:14 25.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:15 26.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:31 27.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:32 28.
Summary
1:10:32 29.
miR-21 reduces SATB1 responses
1:10:33 30.
Summary
1:10:34 31.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:34 32.
Summary
1:10:37 33.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:38 34.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:12:14 35.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:12:14 36.
Summary
1:12:15 37.
miR-21 reduces SATB1 responses
1:13:08 38.
miR-21 reduces SATB1 responses
1:13:45 39.
SATB1-siRNA abrogates Ant-21 treatment effect
1:19:53 40.
Summary
1:20:16 41.
miR-21 promotes lung S100A9 expression and NF-kB activity
1:24:29 42.
The response of SABT1 and S100A9 in COPD progression
1:24:30 43.
miR-21 promotes lung S100A9 expression and NF-kB activity
1:24:33 44.
The response of SABT1 and S100A9 in COPD progression
1:27:45 45.
The correlation of SABT1 and S1009A
1:28:10 46.
Healthy vs. COPD & Scr vs. Ant Treatment
1:30:26 47.
Features of disease progression in COPD
1:32:23 48.
Conclusion

筆記 (0)

未登入或權限不足!

討論

00:00 1.
index 1
14:20 2.
A microRNA-21–mediated SATB1/S100A9/NF-kBaxis promotes chronic obstructive pulmonarydisease pathogenesis
14:47 3.
Slide 2
15:54 4.
Classification of severity in COPD
16:32 5.
The pulmonary function parameter
16:32 6.
The Lung Function Test
16:33 7.
The pulmonary function parameter
16:33 8.
Classification of severity in COPD
16:38 9.
The pulmonary function parameter
22:17 10.
The Lung Function Test
23:00 11.
White blood cells participates in airway inflammation
23:56 12.
So, why the author chose miR-21 as a target gene?
24:23 13.
CS induces lung miR-21 expression in COPD
26:34 14.
miR-21 positive signals in the airway epithium
26:36 15.
CS induces lung miR-21 expression in COPD
31:56 16.
miR-21 positive signals in the airway epithium
43:43 17.
Correlation between miR-21 expression and disease severity in COPD.
53:44 18.
miR-21 expression in different phase of COPD
54:15 19.
Summary
54:43 20.
Inhibition of miR-21 suppresses airway inflammation.
1:02:59 21.
The effectiveness of Ant-21 treatment in COPD
1:04:44 22.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:06:31 23.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:09:50 24.
Summary
1:10:14 25.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:15 26.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:31 27.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:32 28.
Summary
1:10:32 29.
miR-21 reduces SATB1 responses
1:10:33 30.
Summary
1:10:34 31.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:34 32.
Summary
1:10:37 33.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:38 34.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:12:14 35.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:12:14 36.
Summary
1:12:15 37.
miR-21 reduces SATB1 responses
1:13:08 38.
miR-21 reduces SATB1 responses
1:13:45 39.
SATB1-siRNA abrogates Ant-21 treatment effect
1:19:53 40.
Summary
1:20:16 41.
miR-21 promotes lung S100A9 expression and NF-kB activity
1:24:29 42.
The response of SABT1 and S100A9 in COPD progression
1:24:30 43.
miR-21 promotes lung S100A9 expression and NF-kB activity
1:24:33 44.
The response of SABT1 and S100A9 in COPD progression
1:27:45 45.
The correlation of SABT1 and S1009A
1:28:10 46.
Healthy vs. COPD & Scr vs. Ant Treatment
1:30:26 47.
Features of disease progression in COPD
1:32:23 48.
Conclusion

分享
- 嵌入網址
- QR code

索引
筆記
討論
全螢幕

20231127 lab meeting_庭汶

長度: 1:35:40, 瀏覽: 233, 最近修訂: 2023-11-27

00:00 1.
index 1
14:20 2.
A microRNA-21–mediated SATB1/S100A9/NF-kBaxis promotes chronic obstructive pulmonarydisease pathogenesis
14:47 3.
Slide 2
15:54 4.
Classification of severity in COPD
16:32 5.
The pulmonary function parameter
16:32 6.
The Lung Function Test
16:33 7.
The pulmonary function parameter
16:33 8.
Classification of severity in COPD
16:38 9.
The pulmonary function parameter
22:17 10.
The Lung Function Test
23:00 11.
White blood cells participates in airway inflammation
23:56 12.
So, why the author chose miR-21 as a target gene?
24:23 13.
CS induces lung miR-21 expression in COPD
26:34 14.
miR-21 positive signals in the airway epithium
26:36 15.
CS induces lung miR-21 expression in COPD
31:56 16.
miR-21 positive signals in the airway epithium
43:43 17.
Correlation between miR-21 expression and disease severity in COPD.
53:44 18.
miR-21 expression in different phase of COPD
54:15 19.
Summary
54:43 20.
Inhibition of miR-21 suppresses airway inflammation.
1:02:59 21.
The effectiveness of Ant-21 treatment in COPD
1:04:44 22.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:06:31 23.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:09:50 24.
Summary
1:10:14 25.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:15 26.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:31 27.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:32 28.
Summary
1:10:32 29.
miR-21 reduces SATB1 responses
1:10:33 30.
Summary
1:10:34 31.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:34 32.
Summary
1:10:37 33.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:10:38 34.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:12:14 35.
Inhibition of CS-induced lung miR-21 prevents the impairment of lung function
1:12:14 36.
Summary
1:12:15 37.
miR-21 reduces SATB1 responses
1:13:08 38.
miR-21 reduces SATB1 responses
1:13:45 39.
SATB1-siRNA abrogates Ant-21 treatment effect
1:19:53 40.
Summary
1:20:16 41.
miR-21 promotes lung S100A9 expression and NF-kB activity
1:24:29 42.
The response of SABT1 and S100A9 in COPD progression
1:24:30 43.
miR-21 promotes lung S100A9 expression and NF-kB activity
1:24:33 44.
The response of SABT1 and S100A9 in COPD progression
1:27:45 45.
The correlation of SABT1 and S1009A
1:28:10 46.
Healthy vs. COPD & Scr vs. Ant Treatment
1:30:26 47.
Features of disease progression in COPD
1:32:23 48.
Conclusion

位置

資料夾名稱

2023

發表人

周楷軒

單位

賴亮全教授

建立

2023-11-27 12:29:34

最近修訂

2023-11-27 12:55:40

長度

1:35:40